Need professional-grade analysis? Visit stockanalysis.com
$1.87B
86.59
120
N/A
Brainsway Ltd (BWAY) trades on TA in ILS. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at ILS4676.00, down 3.79% from the previous close.
Over the past year, BWAY has traded between a low of ILS1531.00 and a high of ILS4860.00. The stock has gained 205.4% over this period. It is currently 205.4% above its 52-week low.
Brainsway Ltd has a market capitalization of $1.87B, with a price-to-earnings ratio of 86.59.
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Side-by-side comparison against top Healthcare peers.